cll treatment: novel agents vs. cellular therapies
Published 4 years ago • 45 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:01
cll resistance mechanisms in the era of novel agents
-
3:00
how do novel agents affect allogeneic transplantation in cll?
-
0:51
novel therapies in the future of cll treatment
-
2:00
associated toxicities of novel therapies for cll
-
1:29
the importance of treatment sequencing in cll
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
27:49
what's new with cll treatments w/top expert | dr. william wierda, md anderson | the patient story
-
4:18
treatment options for chronic lymphocytic leukemia (cll)
-
3:58
chronic lymphocytic leukemia (cll) - diagnosis and treatment- hematology and oncology series
-
2:36
transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (cll)?
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
0:56
the current treatment landscape in cll
-
1:28
the future of cll treatment
-
1:33
cellular and non-cellular immunotherapies in cll
-
1:30
exciting new agents in cll
-
0:53
the future of cll treatment
-
4:14
novel therapies for the treatment of cll, mcl and fl
-
1:19
cll treatment: a look into the future
-
2:12
can chemoimmunotherapy in cll treatment be replaced with novel agents?
-
1:31
novel approaches to cll treatment
-
2:43
treatment sequencing options for recurrent cll
-
1:36
selecting the best treatment option in cll